# Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection

> **NCT02364583** · PHASE4 · UNKNOWN · sponsor: **Papua New Guinea Institute of Medical Research** · enrollment: 150 (estimated)

## Conditions studied

- Plasmodium Vivax

## Interventions

- **DRUG:** Primaquine

## Key facts

- **NCT ID:** NCT02364583
- **Lead sponsor:** Papua New Guinea Institute of Medical Research
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2015-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02364583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02364583, "Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02364583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*